Hsbc Holdings PLC Agenus Inc Transaction History

Hsbc Holdings PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.53 - $0.93 $23,188 - $40,688	43,751 Added 297.63%	58,451 $33,000
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $21,315 - $43,365	14,700 New	14,700 $22,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $25,699 - $41,171	-13,112 Reduced 29.35%	31,565 $67,000
Q2 2022 Aug 11, 2022	BUY	$1.3 - $2.64 $35,977 - $73,062	27,675 Added 162.77%	44,677 $89,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $4,215 - $6,225	1,794 Added 11.8%	17,002 $42,000
Q4 2021 Feb 11, 2022	BUY	$2.92 - $5.74 $44,407 - $87,293	15,208 New	15,208 $48,000
Q1 2021 May 14, 2021	SELL	$2.69 - $5.25 $35,973 - $70,208	-13,373 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.17 - $4.49 $42,392 - $60,044	13,373 New	13,373 $42,000
Q2 2020 Aug 14, 2020	SELL	$2.29 - $4.24 $48,197 - $89,239	-21,047 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.92 - $4.39 $40,410 - $92,396	21,047 New	21,047 $51,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.